J. J. Hearty

Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry.

UBS Capital focuses on making investments in middle market LBOs, recapitalizations and growth financings. Their investment strategy is opportunistic but disciplined. They seek to identify industries or companies undergoing positive structural changes with above average top line growth prospects. UBS Capital looks to acquire a platform company with strong market position and excellent management team and to create value through the execution of growth business plans, strategic acquisitions and access to financial and strategic resources

Provides brokerage services

Functions as a College/University

Riverside Partners invests in middle-market companies located in the United States primarily in North America with an EBITDA of USD 3 - 15 million. The firm focuses on technology and healthcare sectors. It participates in buyouts, recapitalizations, growth equity, divestitures, take private transactions and strategic add-on acquisitions. It makes control investments.

Functions as a College/University

Two Sigma invests in companies located in the United States. The firm targets companies operating in the fields of education, healthcare, consumer and business services. It provides equity investments in the range of USD 50 - 100 million. It also makes minority and control investments.

Coalesce Capital Management invests in companies located in the United States with an EBITDA up to USD 5 million and revenue of USD 250 million. The firm focuses on companies operating in the fields of broad range of sectors and industries. It provides financing for growth stage capital requirements.